Literature DB >> 11463066

An overview of animal models in experimental schistosomiasis and refinements in the use of non-human primates.

I O Farah1, T M Kariuki, C L King, J Hau.   

Abstract

The complex nature of the schistosome parasite and its interaction with the mammalian host necessitates the continued use of live intact animal models in schistosomiasis research. This review acknowledges this necessity and highlights some of the important insights into the pathogenesis of the disease that have been gained from using various animal models. The use of non-human primates as more relevant models of human schistosomiasis is stated. In addition, the importance of animal welfare consideration when using primates for research is emphasized. Finally, some guidelines for the refined capture, handling and early humane endpoints for non-human primates to be used in experimental schistosomiasis are suggested.

Entities:  

Mesh:

Year:  2001        PMID: 11463066     DOI: 10.1258/0023677011911570

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  16 in total

1.  Morbidity and immune response to natural schistosomiasis in baboons ( Papio anubis).

Authors:  Idle Farah; Andreas Börjesson; Thomas Kariuki; Dorcas Yole; Mbaruk Suleman; Jann Hau; Hans-Erik Carlsson
Journal:  Parasitol Res       Date:  2003-09-18       Impact factor: 2.289

2.  Serum Carbonic Anhydrase 1 is a Biomarker for Diagnosis of Human Schistosoma mansoni Infection.

Authors:  Manal Ibrahim Kardoush; Brian J Ward; Momar Ndao
Journal:  Am J Trop Med Hyg       Date:  2017-04       Impact factor: 2.345

Review 3.  Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies.

Authors:  Rashad A Abdul-Ghani; Azza A Hassan
Journal:  Parasitol Res       Date:  2010-04-06       Impact factor: 2.289

4.  Schistosoma haematobium cercarial infection alters subsequent systemic immune responses to eggs but has minimal impact on immune responses to egg injection of the bladder.

Authors:  Le Loc; Evaristus C Mbanefo; George Khludenev; Olivia Lamanna; Nirad Banskota; Michael H Hsieh
Journal:  Parasite Immunol       Date:  2018-12-03       Impact factor: 2.280

Review 5.  The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Authors:  Paul Ogongo; Ruth K Nyakundi; Gerald K Chege; Lucy Ochola
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

6.  Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.

Authors:  Ruth K Nyakundi; Onkoba Nyamongo; Jeneby Maamun; Mercy Akinyi; Isaac Mulei; Idle O Farah; D'Arbra Blankenship; Brian Grimberg; Jann Hau; Indu Malhotra; Hastings Ozwara; Christopher L King; Thomas M Kariuki
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

7.  Assessment of the subtypes and the zoonotic risk of Blastocystis sp. of experimental macaques in Yunnan province, southwestern China.

Authors:  Ting-Cui Li; Zhao Li; Yu-Lin Zhang; Wen-Jie Chen; Xian-Lan Dong; Jian-Fa Yang; Hong-Xia Li; Feng-Cai Zou
Journal:  Parasitol Res       Date:  2020-01-02       Impact factor: 2.289

Review 8.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

Review 9.  Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

Authors:  Rachel Stephenson; Hong You; Donald P McManus; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2014-09-02

10.  Schistosoma mansoni experimental infection in Mus spretus (SPRET/EiJ strain) mice.

Authors:  Luis Pérez del Villar; Belén Vicente; Purificación Galindo-Villardón; Andrés Castellanos; Jesús Pérez-Losada; Antonio Muro
Journal:  Parasite       Date:  2013-08-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.